Long non-coding RNA TUG1 is up-regulated in hepatocellular carcinoma and promotes cell growth and apoptosis by epigenetically silencing of KLF2.

Abstract:

BACKGROUND:Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death worldwide, and the biology of this cancer remains poorly understood. Recent evidence indicates that long non-coding RNAs (lncRNAs) are found to be dysregulated in a variety of cancers, including HCC. Taurine Up-regulated Gene 1 (TUG1), a 7.1-kb lncRNA, recruiting and binding to polycomb repressive complex 2 (PRC2), is found to be disregulated in non-small cell lung carcinoma (NSCLC) and esophageal squamous cell carcinoma (ESCC). However, its clinical significance and potential role in HCC remain unclear. METHODS AND RESULTS:In this study, expression of TUG1 was analyzed in 77 HCC tissues and matched normal tissues by using quantitative polymerase chain reaction (qPCR). TUG1 expression was up-regulated in HCC tissues and the higher expression of TUG1 was significantly correlated with tumor size and Barcelona Clinic Liver Cancer (BCLC) stage. Moreover, silencing of TUG1 expression inhibited HCC cell proliferation, colony formation, tumorigenicity and induced apoptosis in HCC cell lines. We also found that TUG1 overexpression was induced by nuclear transcription factor SP1 and TUG1 could epigeneticly repress Kruppel-like factor 2 (KLF2) transcription in HCC cells by binding with PRC2 and recruiting it to KLF2 promoter region. CONCLUSION:Our results suggest that lncRNA TUG1, as a growth regulator, may serve as a new diagnostic biomarker and therapy target for HCC.

journal_name

Mol Cancer

journal_title

Molecular cancer

authors

Huang MD,Chen WM,Qi FZ,Sun M,Xu TP,Ma P,Shu YQ

doi

10.1186/s12943-015-0431-0

subject

Has Abstract

pub_date

2015-09-04 00:00:00

pages

165

issn

1476-4598

pii

10.1186/s12943-015-0431-0

journal_volume

14

pub_type

杂志文章
  • Quantitation of cell-free DNA and RNA in plasma during tumor progression in rats.

    abstract:BACKGROUND:To clarify the implications of cell-free nucleic acids (cfNA) in the plasma in neoplastic disease, it is necessary to determine the kinetics of their release into the circulation. METHODS:To quantify non-tumor and tumor DNA and RNA in the plasma of tumor-bearing rats and to correlate such levels with tumor ...

    journal_title:Molecular cancer

    pub_type: 杂志文章

    doi:10.1186/1476-4598-12-8

    authors: García-Olmo DC,Picazo MG,Toboso I,Asensio AI,García-Olmo D

    更新日期:2013-02-04 00:00:00

  • Evaluation of microRNA-10b prognostic significance in a prospective cohort of breast cancer patients.

    abstract:BACKGROUND:MicroRNA-10b (miR-10b) has a prominent role in regulating tumor invasion and metastasis by targeting the HOXD10 transcriptional repressor and has been found up-regulated in several tumor types. METHODS:We evaluated the expression of miR-10b in paired tumor and normal specimens obtained from a prospective co...

    journal_title:Molecular cancer

    pub_type: 杂志文章

    doi:10.1186/1476-4598-13-142

    authors: Parrella P,Barbano R,Pasculli B,Fontana A,Copetti M,Valori VM,Poeta ML,Perrone G,Righi D,Castelvetere M,Coco M,Balsamo T,Morritti M,Pellegrini F,Onetti-Muda A,Maiello E,Murgo R,Fazio VM

    更新日期:2014-06-04 00:00:00

  • MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation.

    abstract:BACKGROUND:MicroRNAs (miRNAs) are involved in cancer development and progression, acting as tumor suppressors or oncogenes. Our previous studies have revealed that miR-148a and miR-152 are significantly down-regulated in gastrointestinal cancers. Interestingly, miR-148b has the same "seed sequences" as miR-148a and miR...

    journal_title:Molecular cancer

    pub_type: 杂志文章

    doi:10.1186/1476-4598-10-1

    authors: Song YX,Yue ZY,Wang ZN,Xu YY,Luo Y,Xu HM,Zhang X,Jiang L,Xing CZ,Zhang Y

    更新日期:2011-01-04 00:00:00

  • Functional studies of BCL11A: characterization of the conserved BCL11A-XL splice variant and its interaction with BCL6 in nuclear paraspeckles of germinal center B cells.

    abstract:BACKGROUND:Chromosomal aberrations of BCL11A at 2p16.1 have been reported in a variety of B-cell malignancies and its deficiency in mice leads to a profound block in B-cell development. RESULTS:Alternative pre-mRNA splicing of BCL11A produces multiple isoforms sharing a common N-terminus. The most abundant isoform we ...

    journal_title:Molecular cancer

    pub_type: 杂志文章

    doi:10.1186/1476-4598-5-18

    authors: Liu H,Ippolito GC,Wall JK,Niu T,Probst L,Lee BS,Pulford K,Banham AH,Stockwin L,Shaffer AL,Staudt LM,Das C,Dyer MJ,Tucker PW

    更新日期:2006-05-16 00:00:00

  • Roles of Sema4D and Plexin-B1 in tumor progression.

    abstract::Sema4D, also known as CD100, is a protein belonging to class IV semaphorin. Its physiologic roles in the immune and nervous systems have been extensively explored. However, the roles of Sema4D have extended beyond these traditionally studied territories. Via interaction with its high affinity receptor Plexin-B1, Sema4...

    journal_title:Molecular cancer

    pub_type: 杂志文章,评审

    doi:10.1186/1476-4598-9-251

    authors: Ch'ng ES,Kumanogoh A

    更新日期:2010-09-21 00:00:00

  • PTTG expression in different experimental and human prolactinomas in relation to dopaminergic control of lactotropes.

    abstract:BACKGROUND:Pituitary tumor transforming gene (pttg) is a novel oncogene that is expressed at higher level in most of the tumors analyzed to date compared to normal tissues. Nevertheless, its expression in prolactinomas and its relation with the pituitary dopamine receptor 2 (D2R) are not well defined. We sought to dete...

    journal_title:Molecular cancer

    pub_type: 杂志文章

    doi:10.1186/1476-4598-6-4

    authors: Cristina C,Díaz-Torga GS,Goya RG,Kakar SS,Perez-Millán MI,Passos VQ,Giannella-Neto D,Bronstein MD,Becu-Villalobos D

    更新日期:2007-01-12 00:00:00

  • Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma.

    abstract:BACKGROUND:Esophageal squamous cell carcinoma (ESCC) is highly malignant with highly invasive and metastatic capabilities and poor prognosis. It is believed that the ESCC cancer stem-like cells (ECSLCs) are critical for tumorigenicity, invasion and metastasis of ESCC. However, the properties of ECSLCs vary with differe...

    journal_title:Molecular cancer

    pub_type: 杂志文章

    doi:10.1186/s12943-017-0650-7

    authors: Liu Q,Cui X,Yu X,Bian BS,Qian F,Hu XG,Ji CD,Yang L,Ren Y,Cui W,Zhang X,Zhang P,Wang JM,Cui YH,Bian XW

    更新日期:2017-04-21 00:00:00

  • RASAL2 promotes tumor progression through LATS2/YAP1 axis of hippo signaling pathway in colorectal cancer.

    abstract:BACKGROUND:Patients with colorectal cancer (CRC) have a high incidence of regional and distant metastases. Although metastasis is the main cause of CRC-related death, its molecular mechanisms remain largely unknown. METHODS:Using array-CGH and expression microarray analyses, changes in DNA copy number and mRNA express...

    journal_title:Molecular cancer

    pub_type: 杂志文章

    doi:10.1186/s12943-018-0853-6

    authors: Pan Y,Tong JHM,Lung RWM,Kang W,Kwan JSH,Chak WP,Tin KY,Chung LY,Wu F,Ng SSM,Mak TWC,Yu J,Lo KW,Chan AWH,To KF

    更新日期:2018-07-23 00:00:00

  • Gene expression time-series analysis of camptothecin effects in U87-MG and DBTRG-05 glioblastoma cell lines.

    abstract:BACKGROUND:The clinical efficacy of camptothecin (CPT), a drug specifically targeting topoisomerase I (TopoI), is under evaluation for the treatment of malignant gliomas. Due to the high unresponsiveness of these tumours to chemotherapy, it would be very important to study the signalling network that drives camptotheci...

    journal_title:Molecular cancer

    pub_type: 杂志文章

    doi:10.1186/1476-4598-7-66

    authors: Morandi E,Severini C,Quercioli D,D'Ario G,Perdichizzi S,Capri M,Farruggia G,Mascolo MG,Horn W,Vaccari M,Serra R,Colacci A,Silingardi P

    更新日期:2008-08-11 00:00:00

  • The chemokine receptor CXCR7 interacts with EGFR to promote breast cancer cell proliferation.

    abstract:BACKGROUND:Recent advances have revealed a significant contribution of chemokines and their receptors in tumor growth, survival after chemotherapy, and organ-specific metastasis. The CXC chemokine receptor-7 (CXCR7) is the latest chemokine receptor implicated in cancer. Although over expressed in breast cancer cell lin...

    journal_title:Molecular cancer

    pub_type: 杂志文章

    doi:10.1186/1476-4598-13-198

    authors: Salazar N,Muñoz D,Kallifatidis G,Singh RK,Jordà M,Lokeshwar BL

    更新日期:2014-08-28 00:00:00

  • Dovitinib synergizes with oxaliplatin in suppressing cell proliferation and inducing apoptosis in colorectal cancer cells regardless of RAS-RAF mutation status.

    abstract:BACKGROUND:Cancer is the result of a multistep process of genomic alterations, including mutations in key regulatory proteins that result in loss of balanced gene expression and subsequent malignant transformation. Throughout the various stages of colorectal carcinoma (CRC), complex genetic alterations occur, of which ...

    journal_title:Molecular cancer

    pub_type: 杂志文章

    doi:10.1186/1476-4598-13-21

    authors: Gaur S,Chen L,Ann V,Lin WC,Wang Y,Chang VH,Hsu NY,Shia HS,Yen Y

    更新日期:2014-02-04 00:00:00

  • Decreased expression of ADAMTS-1 in human breast tumors stimulates migration and invasion.

    abstract:BACKGROUND:ADAMTS-1 (a disintegrin and metalloprotease with thrombospondin motifs) is a member of the ADAMTS family of metalloproteases. Here, we investigated mRNA and protein levels of ADAMTS-1 in normal and neoplastic tissues using qPCR, immunohistochemistry and immunoblot analyses, and we addressed the role of ADAMT...

    journal_title:Molecular cancer

    pub_type: 杂志文章

    doi:10.1186/1476-4598-12-2

    authors: Freitas VM,do Amaral JB,Silva TA,Santos ES,Mangone FR,Pinheiro Jde J,Jaeger RG,Nagai MA,Machado-Santelli GM

    更新日期:2013-01-05 00:00:00

  • microRNA-139-5p exerts tumor suppressor function by targeting NOTCH1 in colorectal cancer.

    abstract:BACKGROUND:miR-139-5p was identified to be significantly down-regulated in colon tumor tissues by miRNA array. We aimed to clarify its biological function, molecular mechanisms and direct target gene in colorectal cancer (CRC). METHODS:The biological function of miR-139-5p was examined by cell growth, cell cycle and a...

    journal_title:Molecular cancer

    pub_type: 杂志文章

    doi:10.1186/1476-4598-13-124

    authors: Zhang L,Dong Y,Zhu N,Tsoi H,Zhao Z,Wu CW,Wang K,Zheng S,Ng SS,Chan FK,Sung JJ,Yu J

    更新日期:2014-05-26 00:00:00

  • MiR-320a acts as a prognostic factor and Inhibits metastasis of salivary adenoid cystic carcinoma by targeting ITGB3.

    abstract:BACKGROUND:Salivary Adenoid cystic carcinoma (SACC) patients with local invasion and lung metastasis are often resistant to conventional therapy such as operation, chemotherapy and radiotherapy. To explore the underling mechanisms, we studied the roles of miRNA in regulating invasiveness of SACC cells. METHODS:MicroRN...

    journal_title:Molecular cancer

    pub_type: 杂志文章

    doi:10.1186/s12943-015-0344-y

    authors: Sun L,Liu B,Lin Z,Yao Y,Chen Y,Li Y,Chen J,Yu D,Tang Z,Wang B,Zeng S,Fan S,Wang Y,Li Y,Song E,Li J

    更新日期:2015-04-29 00:00:00

  • Characteristics of CD44 alternative splice pattern in the course of human colorectal adenocarcinoma progression.

    abstract:BACKGROUND:CD44 is considered as 'a' metastasis associated gene, despite the fact that it is an umbrella term for a group of molecules produced from a single gene by alternative splicing. However, little consideration is given to the above in the literature of colorectal carcinomas as well as other tumour types, leadin...

    journal_title:Molecular cancer

    pub_type: 杂志文章

    doi:10.1186/1476-4598-11-83

    authors: Bánky B,Rásó-Barnett L,Barbai T,Tímár J,Becságh P,Rásó E

    更新日期:2012-11-14 00:00:00

  • Histone demethylase KDM4D promotes gastrointestinal stromal tumor progression through HIF1β/VEGFA signalling.

    abstract:BACKGROUND:Gastrointestinal stromal tumour (GIST) is the most common soft tissue sarcoma. The identification of the molecular mechanisms regulating GIST progression is vital for its treatment and prevention. Increasing reports have demonstrated that epigenetic alterations play critical roles in GIST development. Howeve...

    journal_title:Molecular cancer

    pub_type: 杂志文章

    doi:10.1186/s12943-018-0861-6

    authors: Hu F,Li H,Liu L,Xu F,Lai S,Luo X,Hu J,Yang X

    更新日期:2018-07-30 00:00:00

  • Elimination of head and neck cancer initiating cells through targeting glucose regulated protein78 signaling.

    abstract:BACKGROUND:Head and neck squamous cell carcinoma (HNSCC) is a highly lethal cancer that contains cellular and functional heterogeneity. Previously, we enriched a subpopulation of highly tumorigenic head and neck cancer initiating cells (HN-CICs) from HNSCC. However, the molecular mechanisms by which to govern the chara...

    journal_title:Molecular cancer

    pub_type: 杂志文章

    doi:10.1186/1476-4598-9-283

    authors: Wu MJ,Jan CI,Tsay YG,Yu YH,Huang CY,Lin SC,Liu CJ,Chen YS,Lo JF,Yu CC

    更新日期:2010-10-27 00:00:00

  • Circular RNA: metabolism, functions and interactions with proteins.

    abstract::Circular RNAs (CircRNAs) are single-stranded, covalently closed RNA molecules that are ubiquitous across species ranging from viruses to mammals. Important advances have been made in the biogenesis, regulation, localization, degradation and modification of circRNAs. CircRNAs exert biological functions by acting as tra...

    journal_title:Molecular cancer

    pub_type: 杂志文章,评审

    doi:10.1186/s12943-020-01286-3

    authors: Zhou WY,Cai ZR,Liu J,Wang DS,Ju HQ,Xu RH

    更新日期:2020-12-14 00:00:00

  • Exosomal miR-21 regulates the TETs/PTENp1/PTEN pathway to promote hepatocellular carcinoma growth.

    abstract:BACKGROUND:As an important means of communication, exosomes play an important role in the development of hepatocellular carcinoma (HCC). METHODS:Bioinformatics analysis, dual-luciferase reporter assays, methylation-specific quantitative PCR, and ChIP-PCR analysis were used to gain insight into the underlying mechanism...

    journal_title:Molecular cancer

    pub_type: 杂志文章

    doi:10.1186/s12943-019-1075-2

    authors: Cao LQ,Yang XW,Chen YB,Zhang DW,Jiang XF,Xue P

    更新日期:2019-10-27 00:00:00

  • Effects of AKT inhibitor therapy in response and resistance to BRAF inhibition in melanoma.

    abstract:BACKGROUND:The clinical use of BRAF inhibitors for treatment of metastatic melanoma is limited by the development of drug resistance. In this study we investigated whether co-targeting the MAPK and the PI3K-AKT pathway can prevent emergence of resistance or provide additional growth inhibitory effects in vitro. METHOD...

    journal_title:Molecular cancer

    pub_type: 杂志文章

    doi:10.1186/1476-4598-13-83

    authors: Lassen A,Atefi M,Robert L,Wong DJ,Cerniglia M,Comin-Anduix B,Ribas A

    更新日期:2014-04-16 00:00:00

  • MicroRNA-218 functions as a tumor suppressor in lung cancer by targeting IL-6/STAT3 and negatively correlates with poor prognosis.

    abstract:BACKGROUND:Aberrant expression of microRNAs in different human cancer types has been widely reported. MiR-218 acts as a tumor suppressor in diverse human cancer types impacting regulation of multiple genes in oncogenic pathways. Here, we evaluated the expression and function of miR-218 in human lung cancer and ALDH pos...

    journal_title:Molecular cancer

    pub_type: 杂志文章

    doi:10.1186/s12943-017-0710-z

    authors: Yang Y,Ding L,Hu Q,Xia J,Sun J,Wang X,Xiong H,Gurbani D,Li L,Liu Y,Liu A

    更新日期:2017-08-22 00:00:00

  • Shikonin-enhanced cell immunogenicity of tumor vaccine is mediated by the differential effects of DAMP components.

    abstract:BACKGROUND:The tumor cell lysate-pulsed, dendritic cell (DC)-based cancer vaccine approaches are being actively evaluated for application to cancer immunotherapy, hopefully at a personalized medicine base. There is apparently an emerging technical problem however, the lack of highly efficacious potency in activation of...

    journal_title:Molecular cancer

    pub_type: 杂志文章

    doi:10.1186/s12943-015-0435-9

    authors: Lin TJ,Lin HT,Chang WT,Mitapalli S P,Hsiao PW,Yin SY,Yang NS

    更新日期:2015-09-24 00:00:00

  • Nuclear-enriched abundant transcript 1 as a diagnostic and prognostic biomarker in colorectal cancer.

    abstract:BACKGROUND:High expression of the long non-coding RNA nuclear-enriched abundant transcript 1 (NEAT1) in whole blood has been reported in colorectal cancer patients; however, its' clinical significance and origin are unclear. We evaluated the diagnostic and prognostic value, and origin of whole blood NEAT1 in colorectal...

    journal_title:Molecular cancer

    pub_type: 杂志文章

    doi:10.1186/s12943-015-0455-5

    authors: Wu Y,Yang L,Zhao J,Li C,Nie J,Liu F,Zhuo C,Zheng Y,Li B,Wang Z,Xu Y

    更新日期:2015-11-09 00:00:00

  • ABCG2, a novel antigen to sort luminal progenitors of BRCA1- breast cancer cells.

    abstract:INTRODUCTION:Tumor-initiating cells (TICs), aka "cancer stem cells", are believed to fuel tumors and to sustain therapy resistance and systemic metastasis. Breast cancer is the first human carcinoma in which a subpopulation of cells displaying a specific CD44+/CD24-/low/ESA+ antigenic phenotype was found to have TIC pr...

    journal_title:Molecular cancer

    pub_type: 杂志文章

    doi:10.1186/1476-4598-13-213

    authors: Leccia F,Del Vecchio L,Mariotti E,Di Noto R,Morel AP,Puisieux A,Salvatore F,Ansieau S

    更新日期:2014-09-12 00:00:00

  • Quantitative analysis of the effect of tubulin isotype expression on sensitivity of cancer cell lines to a set of novel colchicine derivatives.

    abstract:BACKGROUND:A maximum entropy approach is proposed to predict the cytotoxic effects of a panel of colchicine derivatives in several human cancer cell lines. Data was obtained from cytotoxicity assays performed with 21 drug molecules from the same family of colchicine compounds and correlate these results with independen...

    journal_title:Molecular cancer

    pub_type: 杂志文章

    doi:10.1186/1476-4598-9-131

    authors: Tseng CY,Mane JY,Winter P,Johnson L,Huzil T,Izbicka E,Luduena RF,Tuszynski JA

    更新日期:2010-05-30 00:00:00

  • The decade of exosomal long RNA species: an emerging cancer antagonist.

    abstract::Exosomes have emerged as a novel approach for the treatment and diagnosis of cancer after RNA content was discovered in exosomes in 2007. As important meditators of intercellular communication, exosomes have become a strong focus of investigation for researchers in the past decade, as witnessed through the exponential...

    journal_title:Molecular cancer

    pub_type: 杂志文章,评审

    doi:10.1186/s12943-018-0823-z

    authors: Zhou R,Chen KK,Zhang J,Xiao B,Huang Z,Ju C,Sun J,Zhang F,Lv XB,Huang G

    更新日期:2018-03-20 00:00:00

  • TGFBI expression is associated with a better response to chemotherapy in NSCLC.

    abstract:BACKGROUND:Lung cancer is one of the most prevalent neoplasias in developed countries. Advances in patient survival have been limited and the identification of prognostic molecules is needed. Resistance to treatment is strongly related to tumor cell adhesion to the extracellular matrix and alterations in the quantity a...

    journal_title:Molecular cancer

    pub_type: 杂志文章

    doi:10.1186/1476-4598-9-130

    authors: Irigoyen M,Pajares MJ,Agorreta J,Ponz-Sarvisé M,Salvo E,Lozano MD,Pío R,Gil-Bazo I,Rouzaut A

    更新日期:2010-05-28 00:00:00

  • HDAC-inhibition counteracts everolimus resistance in renal cell carcinoma in vitro by diminishing cdk2 and cyclin A.

    abstract:BACKGROUND:Targeted therapies have improved therapeutic options of treating renal cell carcinoma (RCC). However, drug response is temporary due to resistance development. METHODS:Functional and molecular changes in RCC Caki-1 cells, after acquired resistance to the mammalian target of rapamycin (mTOR)-inhibitor everol...

    journal_title:Molecular cancer

    pub_type: 杂志文章

    doi:10.1186/1476-4598-13-152

    authors: Juengel E,Nowaz S,Makarevi J,Natsheh I,Werner I,Nelson K,Reiter M,Tsaur I,Mani J,Harder S,Bartsch G,Haferkamp A,Blaheta RA

    更新日期:2014-06-16 00:00:00

  • Shedding of bevacizumab in tumour cells-derived extracellular vesicles as a new therapeutic escape mechanism in glioblastoma.

    abstract::Glioblastoma (GBM) is the most aggressive type of primary brain tumours. Anti-angiogenic therapies (AAT), such as bevacizumab, have been developed to target the tumour blood supply. However, GBM presents mechanisms of escape from AAT activity, including a speculated direct effect of AAT on GBM cells. Furthermore, beva...

    journal_title:Molecular cancer

    pub_type: 信件

    doi:10.1186/s12943-018-0878-x

    authors: Simon T,Pinioti S,Schellenberger P,Rajeeve V,Wendler F,Cutillas PR,King A,Stebbing J,Giamas G

    更新日期:2018-08-31 00:00:00

  • LEDGF/p75 has increased expression in blasts from chemotherapy-resistant human acute myelogenic leukemia patients and protects leukemia cells from apoptosis in vitro.

    abstract:BACKGROUND:Relapse due to chemoresistant residual disease is a major cause of death in acute myelogenous leukemia (AML). The present study was undertaken to elucidate the molecular mechanisms of chemoresistance by comparing differential gene expression in blasts from patients with resistant relapsing AML and chemosensi...

    journal_title:Molecular cancer

    pub_type: 杂志文章

    doi:10.1186/1476-4598-6-31

    authors: Huang TS,Myklebust LM,Kjarland E,Gjertsen BT,Pendino F,Bruserud Ø,Døskeland SO,Lillehaug JR

    更新日期:2007-04-23 00:00:00